Pharmanutra S.p.A. (BIT:PHN)
Italy · Delayed Price · Currency is EUR 82.50
+0.50 (0.61%)
Jul 28, 2026, 11:02 AM CET
Pharmanutra Ratios and Metrics
Market cap in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 785 | 520 | 522 | 542 | 601 | 730 | |
Market Cap Growth | 78.13% | -0.48% | -3.66% | -9.73% | -17.70% | 100.53% |
Enterprise Value | 775.26 | 509.83 | 517.72 | 545.18 | 591.62 | 702.36 |
Last Close Price | 82.50 | 54.30 | 54.40 | 56.40 | 62.30 | 75.40 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 37.26 | 25.98 | 31.45 | 42.41 | 39.94 | 53.10 |
Forward PE | 31.82 | 23.47 | 25.25 | 32.36 | 38.79 | 53.54 |
PEG Ratio | - | 4.14 | 4.14 | 4.14 | 4.14 | 2.65 |
PS Ratio | 5.65 | 3.82 | 4.42 | 5.32 | 7.20 | 10.60 |
PB Ratio | 10.54 | 7.29 | 8.40 | 9.97 | 11.79 | 16.19 |
P/TBV Ratio | 15.79 | 11.11 | 13.43 | 17.11 | 20.50 | 18.44 |
P/FCF Ratio | 49.02 | 31.65 | 32.30 | - | - | 47.32 |
P/OCF Ratio | 40.37 | 26.58 | 25.58 | 44.85 | 34.40 | 35.76 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 5.58 | 3.74 | 4.38 | 5.35 | 7.09 | 10.20 |
EV/EBITDA Ratio | 21.85 | 14.90 | 16.54 | 20.59 | 24.29 | 34.98 |
EV/EBIT Ratio | 24.62 | 16.82 | 18.91 | 23.34 | 25.68 | 37.58 |
EV/FCF Ratio | 48.41 | 31.03 | 32.01 | - | - | 45.53 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.26 | 0.29 | 0.39 | 0.51 | 0.35 | 0.14 |
Debt / EBITDA Ratio | 0.54 | 0.60 | 0.78 | 1.06 | 0.73 | 0.32 |
Debt / FCF Ratio | 1.19 | 1.25 | 1.50 | - | - | 0.41 |
Net Debt / Equity Ratio | -0.13 | -0.14 | -0.08 | 0.05 | -0.18 | -0.61 |
Net Debt / EBITDA Ratio | -0.28 | -0.29 | -0.15 | 0.11 | -0.37 | -1.37 |
Net Debt / FCF Ratio | -0.62 | -0.61 | -0.29 | -2.50 | 1.05 | -1.79 |
Asset Turnover | 0.81 | 1.12 | 1.03 | 0.96 | 0.97 | 1.12 |
Inventory Turnover | 0.57 | 1.02 | 0.47 | 1.17 | 1.66 | 1.78 |
Quick Ratio | 1.84 | 1.81 | 1.89 | 1.64 | 1.96 | 3.08 |
Current Ratio | 2.38 | 2.35 | 2.38 | 2.12 | 2.28 | 3.31 |
Return on Equity (ROE) | 28.75% | 29.87% | 28.40% | 24.36% | 31.34% | 22.85% |
Return on Assets (ROA) | 18.02% | 16.48% | 14.51% | 12.12% | 17.26% | 22.24% |
Return on Invested Capital (ROIC) | 36.32% | 33.73% | 29.07% | 26.00% | 49.93% | 37.08% |
Return on Capital Employed (ROCE) | 32.99% | 32.90% | 31.31% | 29.35% | 35.73% | 39.28% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 2.68% | 3.85% | 3.18% | 2.36% | 2.50% | 1.88% |
FCF Yield | 2.04% | 3.16% | 3.10% | - | - | 2.11% |
Dividend Yield | 1.46% | 1.84% | 1.56% | 1.41% | 1.14% | 0.89% |
Payout Ratio | 45.62% | 47.95% | 49.21% | 60.12% | 45.53% | 47.10% |
Buyback Yield / Dilution | 0.54% | 0.16% | 0.67% | 0.05% | 0.09% | 0.00% |
Total Shareholder Return | 2.00% | 2.01% | 2.23% | 1.46% | 1.23% | 0.89% |